Long-term HIV dynamic models incorporating drug adherence and resistance to treatment for prediction of virological responses
From MaRDI portal
Publication:1023715
DOI10.1016/j.csda.2007.12.016zbMath1452.62812OpenAlexW1983402852MaRDI QIDQ1023715
Publication date: 12 June 2009
Published in: Computational Statistics and Data Analysis (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.csda.2007.12.016
Computational methods for problems pertaining to statistics (62-08) Applications of statistics to biology and medical sciences; meta analysis (62P10) Bayesian inference (62F15) Medical applications (general) (92C50)
Related Items (3)
A mathematical model for HIV treatment with time-varying antiretroviral therapy ⋮ Bayesian binary regression with exponential power link ⋮ Inference in HIV dynamics models via hierarchical likelihood
Uses Software
Cites Work
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- HIV-1 infection and low steady state viral loads
- Estimating the dimension of a model
- Modeling HIV dynamics and antiviral response with consideration of time-varying drug exposures, adherence and phenotypic sensitivity
- Models and estimation methods for clinical HIV-1 data
- The Bayesian Analysis of Population Pharmacokinetic Models
- A Bayesian approach for estimating antiviral efficacy in HIV dynamic models
- Sampling-Based Approaches to Calculating Marginal Densities
- Stochastic Relaxation, Gibbs Distributions, and the Bayesian Restoration of Images
- Mathematical Analysis of HIV-1 Dynamics in Vivo
- Mixed-Effects Models in S and S-PLUS
- Population HIV‐1 Dynamics In Vivo: Applicable Models and Inferential Tools for Virological Data from AIDS Clinical Trials
- Bayesian Measures of Model Complexity and Fit
- Bayesian Analysis of Linear and Non-Linear Population Models by Using the Gibbs Sampler
- Hierarchical Bayesian Methods for Estimation of Parameters in a Longitudinal HIV Dynamic System
This page was built for publication: Long-term HIV dynamic models incorporating drug adherence and resistance to treatment for prediction of virological responses